()
 
 

Overview

Biotech has developed an important new anti-diabetic medication, which has been trademarked as "Sucanon" and "Diab II". Biotech is now focused on the distribution and marketing of this medication. The Company also looks forward to development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world's most widespread and rapidly growing diseases.


Contact Information

#160 - 3751 Shell Road
Richmond, BC V6X2W2

tel: 604-736-3351
fax:
http://www.biotechltd.com

,  



Investor Relations


Management
tel:
fax:
e-mail:




Stock

Exchange: OTCBB
Industry: Drugs
Market Cap: N/A




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.